•
Sep 30, 2022

Selecta Biosciences Q3 2022 Earnings Report

Total Revenue
$20.7M
Previous year: $24.4M
-15.2%
EPS
-$0.05
Previous year: -$0.16
-68.8%
Gross Profit
$20.7M
Previous year: $24.4M
-15.2%
Cash and Equivalents
$113M
Previous year: $115M
-1.6%
Free Cash Flow
$3.92M
Previous year: -$10.9M
-135.9%
Total Assets
$178M
Previous year: $167M
+6.6%

Selecta Biosciences

Selecta Biosciences